BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20662692)

  • 1. Contrast-induced nephropathy after a second contrast exposure.
    Trivedi H; Foley WD
    Ren Fail; 2010; 32(7):796-801. PubMed ID: 20662692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification nomogram for nephropathy after abdominal contrast-enhanced computed tomography.
    Kim KS; Kim K; Hwang SS; Jo YH; Lee CC; Kim TY; Rhee JE; Suh GJ; Singer AJ; Kim HD
    Am J Emerg Med; 2011 May; 29(4):412-7. PubMed ID: 20825813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Review of Contrast Nephropathy in a General Population.
    Arayan A; Nigogosyan MA; Van Every MJ
    WMJ; 2015 Jun; 114(3):95-9. PubMed ID: 27073827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contrast-induced nephropathy after computer tomography. Hydration and adapted contrast media dosage for the best prophylaxis].
    Haglund M; Hesselstrand R; Nyman U; Sterner G
    Lakartidningen; 2005 Oct 3-9; 102(40):2864-6, 2869-70. PubMed ID: 16255363
    [No Abstract]   [Full Text] [Related]  

  • 6. Small-bowel angioedema during screening computed tomography due to intravenous contrast material.
    Park SW; Bae IY; Eun HW; Park HW; Choe JW
    J Comput Assist Tomogr; 2011; 35(5):549-52. PubMed ID: 21926847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous contrast agents for CT studies in children.
    Cohen MD; Herman E; Herron D; White SJ; Smith JA
    Acta Radiol; 1992 Nov; 33(6):592-5. PubMed ID: 1449887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media.
    LaBounty TM; Shah M; Raman SV; Lin FY; Berman DS; Min JK
    Am J Cardiol; 2012 Jun; 109(11):1594-9. PubMed ID: 22440116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
    Schmiedel E
    Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.
    Cernigliaro JG; Haley WE; Adolphson DP; Jepperson MA; Crook JE; Thomas CS; Parker AS
    Clin Imaging; 2016; 40(5):902-6. PubMed ID: 27183138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study].
    Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P
    Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late adverse reactions of non-ionic intravenous contrast media].
    Nambu T; Yoshikawa H; Shirato H; Suzuki K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Aug; 50(8):1019-21. PubMed ID: 2235336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug eruption caused by nonionic iodinated X-ray contrast media.
    Akiyama M; Nakada T; Sueki H; Fujisawa R; Iijima M
    Acad Radiol; 1998 Apr; 5 Suppl 1():S159-61. PubMed ID: 9561070
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
    Chicaíza-Becerra LA; García-Molina M; Gamboa Ó
    Biomedica; 2012 Jun; 32(2):182-8. PubMed ID: 23242291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
    Pinès E; Zamia P; Idée JM
    J Invasive Cardiol; 2005 Feb; 17(2):123-4. PubMed ID: 15770762
    [No Abstract]   [Full Text] [Related]  

  • 16. Immediate complications of intravenous contrast for computed tomography imaging in the outpatient setting are rare.
    Mitchell AM; Jones AE; Tumlin JA; Kline JA
    Acad Emerg Med; 2011 Sep; 18(9):1005-9. PubMed ID: 21854485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In response to: K. Vijayalakshmi, et al, vol. 16, no. 12, pp. 707-711: A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
    Gayet JL; Lefevre T
    J Invasive Cardiol; 2005 Feb; 17(2):124. PubMed ID: 15770763
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing Intravenous Contrast Extravasation in CT: A Simple Solution.
    Conner B; Ash R; Allen W; Brown T; Hill J; Hook M; Fishback S
    J Am Coll Radiol; 2017 Oct; 14(10):1326-1332. PubMed ID: 28739321
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
    Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of contrast-induced nephropathy with volume supplementation--insights from a large cohort.
    Mueller-Lenke N; Buerkle G; Klima T; Breidthardt T; Buettner HJ; Mueller C
    Med Princ Pract; 2008; 17(5):409-14. PubMed ID: 18685283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.